View webinar on demand
Find out how diet affects the risk of mouth and gastrointestinal cancers, and learn about how people can reduce their risk of developing the disease
Learn how SenoBright can give answers sooner in breast cancer diagnosis, spotlighting areas that may not be visible on a standard mammogram or ultrasound. Listen to the team at Pink Lotus talk about the power of reducing patients’ wait time after an inconclusive mammogram.
Molecular profiling metastatic colorectal cancer (mCRC) patients’ tumors have become a central aspect of a personalized therapy approach to treating mCRC.
Over the last decade, evidence has proven that by identifying particular biomarkers in metastatic colorectal cancer (mCRC) patients’ tumor, treatment decisions can be made to ensure that patients receive the most effective treatment for them.
In our final video exploring the continuum of care in recurrent/metastatic head and neck cancer, Professor Jan Vermorken discusses the use of targeted therapies and the role of immunotherapy in this challenging cancer.
Our focus on treatment options for patients with recurrent/metastatic head & neck cancer continues in this interview with Dr Lisa Licitra, who discusses the use of targeted therapies and the role of immunotherapy in this challenging cancer.
Experts in the field of head & neck cancer, Professor Jan Vermorken, Dr Lisa Licitra and Dr Ana Castro, come together to discuss the standard of care for the treatment of recurrent/metastatic disease in this exclusive panel discussion video.
Discover more about the current landscape of treatment for recurrent/metastatic head and neck cancer in this video interview with Dr Ana Castro – Medical Oncologist from Centro Hospitalar do Porto (Portugal).
GE Healthcare introduces the contrast enhanced spectral mammography exam. With SenoBright, you can give your patients a confident diagnosis the same day, in the same place, in less than 7 minutes after the inconclusive mammogram.